BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31301220)

  • 1. An immune infiltration signature to predict the overall survival of patients with colon cancer.
    Peng D; Wang L; Li H; Cai C; Tan Y; Xu B; Le H
    IUBMB Life; 2019 Nov; 71(11):1760-1770. PubMed ID: 31301220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiles for a prognostic immunoscore in gastric cancer.
    Zeng D; Zhou R; Yu Y; Luo Y; Zhang J; Sun H; Bin J; Liao Y; Rao J; Zhang Y; Liao W
    Br J Surg; 2018 Sep; 105(10):1338-1348. PubMed ID: 29691839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
    Li X; Wen D; Li X; Yao C; Chong W; Chen H
    Front Immunol; 2020; 11():1678. PubMed ID: 33013820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I-III colon cancer.
    Zhou R; Zhang J; Zeng D; Sun H; Rong X; Shi M; Bin J; Liao Y; Liao W
    Cancer Immunol Immunother; 2019 Mar; 68(3):433-442. PubMed ID: 30564892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
    Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
    Front Immunol; 2021; 12():769685. PubMed ID: 35003085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer.
    Wang H; Xu F; Zhang M; Liu J; Wang F; Zhao Q
    DNA Cell Biol; 2020 Jul; 39(7):1181-1193. PubMed ID: 32397747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer.
    Zhou R; Zeng D; Zhang J; Sun H; Wu J; Li N; Liang L; Shi M; Bin J; Liao Y; Huang N; Liao W
    EBioMedicine; 2019 Apr; 42():420-430. PubMed ID: 30917936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer.
    Zhang X; Zhao H; Shi X; Jia X; Yang Y
    Aging (Albany NY); 2020 Dec; 12(24):26095-26120. PubMed ID: 33401247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of tumor microenvironment-related genes in colon cancer.
    Luo R; Guo W; Wang H
    Clin Transl Oncol; 2021 Sep; 23(9):1769-1781. PubMed ID: 33689097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma.
    Zhou H; Zheng C; Huang DS
    PeerJ; 2020; 8():e9658. PubMed ID: 32844062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
    Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
    Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer.
    Zhang Q; Feng Z; Zhang Y; Shi S; Zhang Y; Ren S
    Biomed Res Int; 2021; 2021():6057948. PubMed ID: 34124251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer.
    Yang S; Liu T; Cheng Y; Bai Y; Liang G
    Cancer Sci; 2019 Dec; 110(12):3639-3649. PubMed ID: 31605436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
    Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
    Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis.
    Luo J; Liu P; Wang L; Huang Y; Wang Y; Geng W; Chen D; Bai Y; Yang Z
    BMC Cancer; 2020 Nov; 20(1):1071. PubMed ID: 33167940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
    Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients.
    Mo X; Huang X; Feng Y; Wei C; Liu H; Ru H; Qin H; Lai H; Wu G; Xie W; Jeen F; Lin Y; Liu J; Tang W
    Oncoimmunology; 2020 Oct; 9(1):1832347. PubMed ID: 33117604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.